Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 23802084)

4.
5.
6.

Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1.

Ding C, Wang L, Marroquin J, Yan J.

Blood. 2008 Oct 1;112(7):2817-25. doi: 10.1182/blood-2008-05-157396. Epub 2008 Jul 31.

7.

Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.

Sivinski CL, Kohlgraf KG, VanLith ML, Morikane K, Tempero RM, Hollingsworth MA.

Cancer Immunol Immunother. 2002 Aug;51(6):327-40. Epub 2002 May 4.

PMID:
12111121
8.

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer.

Ramanathan RK, Lee KM, McKolanis J, Hitbold E, Schraut W, Moser AJ, Warnick E, Whiteside T, Osborne J, Kim H, Day R, Troetschel M, Finn OJ.

Cancer Immunol Immunother. 2005 Mar;54(3):254-64. Epub 2004 Sep 14.

PMID:
15372205
9.

Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1).

Kohlgraf KG, Gawron AJ, Higashi M, VanLith ML, Shen X, Caffrey TC, Anderson JM, Hollingsworth MA.

Cancer Immunol Immunother. 2004 Dec;53(12):1068-84.

PMID:
15696607
10.

Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.

Ryan SO, Vlad AM, Islam K, GariƩpy J, Finn OJ.

Biol Chem. 2009 Jul;390(7):611-8. doi: 10.1515/BC.2009.070.

PMID:
19426130
11.

Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.

Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ.

J Immunother. 2003 Jan-Feb;26(1):47-62.

PMID:
12514429
12.

Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin.

Kontani K, Taguchi O, Ozaki Y, Hanaoka J, Sawai S, Inoue S, Abe H, Hanasawa K, Fujino S.

Int J Mol Med. 2003 Oct;12(4):493-502.

PMID:
12964025
13.
14.

A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene.

Choi DH, Woo JK, Choi Y, Seo HS, Kim CW.

Mol Med Rep. 2011 Sep-Oct;4(5):885-90. doi: 10.3892/mmr.2011.525. Epub 2011 Jul 1.

PMID:
21725596
15.

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.

Brossart P, Heinrich KS, Stuhler G, Behnke L, Reichardt VL, Stevanovic S, Muhm A, Rammensee HG, Kanz L, Brugger W.

Blood. 1999 Jun 15;93(12):4309-17.

16.

MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.

Gad M, Jensen T, Gagne R, Komba S, Daugaard S, Kroman N, Meldal M, Werdelin O.

Eur J Immunol. 2003 Jun;33(6):1624-32.

PMID:
12778480
17.

Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.

Kontani K, Taguchi O, Ozaki Y, Hanaoka J, Tezuka N, Sawai S, Inoue S, Fujino S, Maeda T, Itoh Y, Ogasawara K, Sato H, Ohkubo I, Kudo T.

Cancer Gene Ther. 2002 Apr;9(4):330-7.

18.

Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.

Kim SK, Ragupathi G, Cappello S, Kagan E, Livingston PO.

Vaccine. 2000 Oct 15;19(4-5):530-7.

PMID:
11027818
19.

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines.

Acres B, Apostolopoulos V, Balloul JM, Wreschner D, Xing PX, Ali-Hadji D, Bizouarne N, Kieny MP, McKenzie IF.

Cancer Immunol Immunother. 2000 Jan;48(10):588-94.

PMID:
10630311
20.

Influence of organ site and tumor cell type on MUC1-specific tumor immunity.

Morikane K, Tempero R, Sivinski CL, Kitajima S, Gendler SJ, Hollingsworth MA.

Int Immunol. 2001 Feb;13(2):233-40.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk